PDS Biotechnology Corp reports results for the quarter ended June 30 - Earnings Summary

Reuters
2025.08.13 13:31
portai
I'm PortAI, I can summarize articles.

PDS Biotechnology Corp reported a quarterly adjusted loss of 21 cents per share for the quarter ended June 30, an improvement from a loss of 23 cents in the same quarter last year. The company reported a total loss of $9.43 million with zero revenue. Analysts had expected a loss of 23 cents per share. PDS shares fell 7.5% this quarter and 24.5% year-to-date. The average analyst rating is "buy" with a 12-month price target of $5.00, indicating a potential upside of 75.4% from the last closing price of $1.23.

  • PDS Biotechnology Corp (PDSB.OQ) reported a quarterly adjusted loss of 21 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -23 cents. The mean expectation of three analysts for the quarter was for a loss of 23 cents per share. Wall Street expected results to range from -25 cents to -22 cents per share.
  • Reported revenue was zero​; analysts expected zero.
  • PDS Biotechnology Corp’s reported EPS for the quarter was a loss of 21 cents​.
  • The company reported a quarterly loss of $9.43 million.
  • PDS Biotechnology Corp shares had fallen by 7.5% this quarter and lost 24.5% so far this year. FORECAST CHANGES
  • The mean earnings estimate of analysts had risen by about 5.4% in the last three months.​
  • In the last 30 days, there have been no earnings estimate revisions by analysts covering the company. RECOMMENDATIONS
  • The current average analyst rating on the shares is “buy” and the breakdown of recommendations is 3 “strong buy” or “buy,” no “hold” and no “sell” or “strong sell.” The average consensus recommendation for the biotechnology & medical research peer group is also “buy”
  • Wall Street’s median 12-month price target for PDS Biotechnology Corp is $5.00, about 75.4% above its last closing price of $1.23 This summary was machine generated from LSEG data August 13 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,

MISSED

Jun. 30 2025 -0.23 -0.21 Beat

Mar. 31 2025 -0.25 -0.21 Beat

Dec. 31 2024 -0.28 -0.21 Beat

Sep. 30 2024 -0.28 -0.29 Missed

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.